HANGZHOU, China, April 19,
2023 /PRNewswire/ -- China
Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) ("Jo-Jo Drugstores" or
the "Company"), a leading online and offline retailer, wholesale
distributor of pharmaceutical and other healthcare products and
healthcare provider in China,
announced today that the previously announced registered direct
offering to issue 2,258,888 ordinary shares and registered warrants
to purchase up to 4,517,776 ordinary shares to an institutional
investor was terminated. No securities were sold pursuant to the
Company's shelf registration statement on Form F-3 (No. 333-259692)
in connection with such previously proposed offering.
About China Jo-Jo Drugstores,
Inc.
China Jo-Jo Drugstores, Inc.
("Jo-Jo Drugstores" or the "Company"), is a leading online and
offline retailer and wholesale distributor of pharmaceutical and
other healthcare products and a provider of healthcare services in
China. Jo-Jo Drugstores currently
operates an online pharmacy and retail drugstores with licensed
doctors on site for consultation, examination and treatment of
common ailments at scheduled hours. It is also a wholesale
distributor of products similar to those carried in its pharmacies.
For more information about the Company, please visit
http://jiuzhou360.com. The Company routinely posts important
information on its website.
Forward-Looking Statements
This press release contains information about the Company's view
of its future expectations, plans and prospects that constitute
forward-looking statements. Actual results may differ materially
from historical results or those indicated by these forward-looking
statements as a result of a variety of factors including, but not
limited to, risks and uncertainties associated with its ability to
raise additional funding, its ability to maintain and grow its
business, variability of operating results, its ability to maintain
and enhance its brand, its development and introduction of new
products and services, the successful integration of acquired
companies, technologies and assets into its portfolio of products
and services, marketing and other business development initiatives,
competition in the industry, general government regulation,
economic conditions, dependence on key personnel, the ability to
attract, hire and retain personnel who possess the technical skills
and experience necessary to meet the requirements of its clients,
and its ability to protect its intellectual property. The Company's
encourages you to review other factors that may affect its future
results in the Company's annual reports and in its other filings
with the Securities and Exchange Commission.
For more information, please contact:
Company Contact:
Frank Zhao
Chief Financial Officer
+86-571-88077108
frank.zhao@jojodrugstores.com
Investor Relations Contact:
Tina Xiao
Ascent Investor Relations LLC
+1-917-609-0333
tina.xiao@ascent-ir.com
View original
content:https://www.prnewswire.com/news-releases/china-jo-jo-drugstores-announces-the-termination-of-the-previously-proposed-registered-direct-offering-301801291.html
SOURCE China Jo-Jo Drugstores,
Inc.